Bluejay Diagnostics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Bluejay Diagnostics, Inc. (BJDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.00 thousand shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-03-28
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 0.00 shares.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was -19.00K shares, a 290.00% decline year-over-year.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-03-31 was 20.00K shares, a 90.75% decline year-over-year.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.00K shares, a 99.58% decline from fiscal 2022.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 236.28K shares, a 15.31% decline from fiscal 2021.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 279.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-28 | -19.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 1.00K shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -19.00K shares derived: sum of 2 quarters · filed 2023-11-09 | 1.00K shares 10-Q · filed 2023-11-09 | 11.00K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -19.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 1.00K shares 10-Q · filed 2023-08-14 | 11.00K shares derived: sum of 3 quarters · filed 2023-08-14 | 11.00K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 20.00K shares 10-Q · filed 2023-05-11 | 30.00K shares derived: sum of 2 quarters · filed 2023-05-11 | 30.00K shares derived: sum of 3 quarters · filed 2023-05-11 | 40.00K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 10.00K shares derived: sum of 2 quarters · filed 2023-03-20 | 20.00K shares derived: sum of 3 quarters · filed 2023-03-20 | 236.28K shares 10-K · filed 2023-03-20 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 10.00K shares derived: sum of 2 quarters · filed 2022-11-09 | 226.28K shares 10-Q · filed 2022-11-09 | 315.28K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 10.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 226.28K shares 10-Q · filed 2022-08-10 | 315.28K shares derived: sum of 3 quarters · filed 2022-08-10 | |
| 2022-03-31 | 216.28K shares 10-Q · filed 2022-05-09 | 305.28K shares derived: sum of 2 quarters · filed 2022-05-09 | ||
| 2021-12-31 | 89.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 279.00K shares 10-K · filed 2022-03-10 | ||
| 2021-09-30 | 190.00K shares 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |